Delivery Order SPE2DB24D2010-SPE2DB25FZVB8
Award Date
2/3/25
Potential Completion Date
2/25/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,119.36 delivery order contract is for the supply of INQOVI 35 MG-100 MG TABLET medical products. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication INQOVI 35 MG-100 MG TABLET. The order is valued at $4,830.47 and has a period of performance through August 6, 2024. The contract is a firm fixed-price vehicle, with no set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen leverages its extensive supply chain to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,119.36, is for the delivery of the pharmaceutical product INQOVI 35 MG-100 MG TABLET. It is a Firm Fixed Price Delivery Order contract, with a completion date of February 6, 2025. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,830.47 firm-fixed-price contract is for the delivery of INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a performance period through April 15, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,119.36 and is a Firm Fixed Price Delivery Order that runs through February 26, 2025. The contract is not designated as a set-aside. The contract covers the delivery of the pharmaceutical product INQOVI 35 MG-100 MG TABLET, which is likely used in federal healthcare programs, potentially...
This is a $9,660.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for INQOVI 35 MG-100 MG tablets, a pharmaceutical product, with a completion date of January 30, 2024. The contract has no set-aside designation. AmerisourceBergen Drug Corp has received numerous federal contracts to supply pharmaceuticals, medical supplies, and distribution services...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies. The contract has a ceiling value of $15,152.80 and runs through July 2021. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of pharmaceutical products, including a tablet medication. The contract has a ceiling value of $13,929.10 and a completion date of January 13, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,028.56 firm-fixed-price contract will run through February 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of pharmaceutical products including tablets, creams, and injectable medications. The $3,104.55 firm fixed price contract has a completion date of November 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...